Literature DB >> 28473293

Moesin and merlin regulate urokinase receptor-dependent endothelial cell migration, adhesion and angiogenesis.

Bernard Degryse1, Mishan Britto2, Chun Xu Shan2, Robert G Wallace2, Keith D Rochfort2, Philip M Cummins2, Gerardene Meade2, Ronan P Murphy2.   

Abstract

The glycosyl-phosphatidyl-inositol (GPI)-anchored urokinase receptor (uPAR) has no intracellular domain, but nevertheless initiates signalling through proximal interactions with other membrane receptors including integrins. The relationships between uPAR and ezrin/radixin/moesin (ERM) proteins, moesin and merlin have never been explored. Moesin and merlin are versatile membrane-actin links and regulators of receptors signalling, respectively. We show that uPAR controls moesin and merlin, which propagate uPAR-initiated signals and modulate integrin functions, thereby regulating uPAR activity. uPAR rapidly de-phosphorylates moesin and phosphorylates merlin inactivating both proteins, and enhancing cell migration and angiogenesis. Moesin behaves as a molecular switch turning either on or off uPAR signalling through cycles of de-activation/activation, or sustained activation, respectively. Furthermore, moesin is at the crossroads of uPAR-initiated outside-in and inside-out signalling promoting integrin-dependent cell adhesion suggesting that uPAR also activates integrins distally through moesin. Knocking down merlin expression enhanced cell migration and adhesion through different regulation of fibronectin- and vitronectin-binding integrins.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Angiogenesis; Cell adhesion; Cell migration; Merlin; Moesin; Urokinase receptor

Mesh:

Substances:

Year:  2017        PMID: 28473293     DOI: 10.1016/j.biocel.2017.04.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

2.  Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.

Authors:  Paola Merino; Ariel Diaz; Luis Guillermo Manrique; Lihong Cheng; Manuel Yepes
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

3.  Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR.

Authors:  Bernard Degryse; Mishan Britto; Chun Xu Shan; Robert G Wallace; Keith D Rochfort; Philip M Cummins; Gerardene Meade; Ronan P Murphy
Journal:  Data Brief       Date:  2017-10-16

4.  Influence of a Hyperglycemic Microenvironment on a Diabetic Versus Healthy Rat Vascular Endothelium Reveals Distinguishable Mechanistic and Phenotypic Responses.

Authors:  Dhanush Haspula; Andrew K Vallejos; Timothy M Moore; Namrata Tomar; Ranjan K Dash; Brian R Hoffmann
Journal:  Front Physiol       Date:  2019-05-10       Impact factor: 4.566

5.  Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor.

Authors:  Federico Furlan; Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Valentina Citro; Maria Vittoria Cubellis; Andrea Motta; Bernard Degryse
Journal:  Data Brief       Date:  2019-01-09

6.  Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression.

Authors:  Suhail Ahmed; Sathishkumar Kurusamy; Ezra Leander Santhosh David; Kinza Khan; Krithika Kalyanakrishnan; Miebaka Ian-Gobo; Teja Manidhar Kola; Robert N Wilkinson; Vinodh Kannappan; Weiguang Wang; Manuel J Gómez; Juan Miguel Redondo; James Cotton; Angel L Armesilla
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.